Target intelligence / Profile preview

Solute carrier family 48 member 1 (SLC48A1)

Target
SLC48A1
Molecular classification
Transporter, Solute carrier family protein (SLC family; member of SLC48), Heme transporter, Membrane protein, Four transmembrane domain protein
01

Overview

Solute carrier family 48 member 1 (SLC48A1; HRG1) is a protein-coding membrane transporter essential for intracellular heme transport and iron homeostasis. It is primarily located in the lysosomal and endosomal membranes, where it mediates the export of heme from the lumen to the cytoplasm during erythrophagocytosis in reticuloendothelial system macrophages. This process is vital for iron recycling from senescent red blood cells, supporting ongoing erythropoiesis and preventing iron deficiency or overload[2][3][4]. SLC48A1 is highly expressed in mature oligodendrocytes in the CNS, where it imports heme to support iron acquisition, with knockout models displaying myelin defects and impaired myelin-associated glycoprotein expression, linking its function to neural integrity and neurodegenerative risk[1]. Deficiency of SLC48A1 results in accumulation of hemozoin (a crystalline heme deposit) in macrophages, mirroring adaptations seen in certain parasites but leading to metabolic challenges and anemia in mammals[2]. Diseases associated with its malfunction include anemia, iron overload syndromes, neurodegeneration, and developmental disorders. Although there are currently no approved drugs that directly target SLC48A1, it is considered a critical transporter for therapeutic modulation of iron and heme metabolism in relevant disease contexts[2][3][4].

Other names
Heme transporter HRG1HRG1Heme-responsive gene 1 protein homologFLJ20489HRGHRG-1hHRG-1Solute carrier family 48 member 1Solute carrier family 48 (heme transporter), member 1
02

Mechanism of action

For experimental heme/iron modulators: Inhibition or enhancement of heme transport across lysosomal/endosomal membranes. Alteration of intracellular iron recycling in erythrophagocytosis. Impact on iron availability in myelination processes in CNS. Modulation of iron-dependent biosynthetic/catabolic pathways in cells.

03

Biological functions

Heme transport (from lysosomes/endosomes to cytoplasm)Intracellular iron homeostasisIron recycling (critical during erythrophagocytosis in macrophages)Myelin integrity (in oligodendrocytes/myelinating cells)Accessory pathway for iron acquisitionRegulation of heme availability for biosynthetic or catabolic processes
04

Disease associations

Iron overloadAnemia (deficiency causes anemia by impairing iron recycling)Neurodegeneration (myelin defects due to iron deficiency in oligodendrocytes)Proliferative vasculopathy and hydranencephaly-hydrocephaly syndromePotential contributor to idiopathic iron disorders (human mutations hypothesized)Myelin adhesion deficiency (linked to defective myelin-associated glycoprotein expression)
05

Safety considerations

Heme toxicity (SLC48A1-deficient animals avoid heme toxicity via hemozoin crystallization, but this adaptation is not present in humans. Excess heme or iron can be cytotoxic.)Anemia risk (impairment leads to iron-deficiency anemia)Risk of neurodegeneration (due to myelin defects from iron starvation)Potential off-target iron dysregulation (affecting CNS and hematopoietic compartments)Iron overload or deficiency with chronic modulation, potential metabolic side effects
06

Interacting drugs

No direct clinically approved drugs currently target SLC48A1, but small molecule inhibitors or activators may modulate its function experimentally. Literature does not list any named drugs directly interacting.
07

Biomarkers

Hemozoin accumulation (indicator of SLC48A1 loss-of-function in macrophages)Iron deficiency markers (anemia, low myelin iron levels in oligodendrocytes)Myelin associated glycoprotein (MAG) expression (decreased in SLC48A1-deficiency)Erythrophagocytic activity and iron recycling metrics in reticuloendothelial system

Beyond the preview

Go deeper on Solute carrier family 48 member 1 (SLC48A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 48 member 1 (SLC48A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call